CN105661542A - Lipid-reducing healthcare oil - Google Patents
Lipid-reducing healthcare oil Download PDFInfo
- Publication number
- CN105661542A CN105661542A CN201610032010.2A CN201610032010A CN105661542A CN 105661542 A CN105661542 A CN 105661542A CN 201610032010 A CN201610032010 A CN 201610032010A CN 105661542 A CN105661542 A CN 105661542A
- Authority
- CN
- China
- Prior art keywords
- oil
- weight
- water
- add
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 239000003921 oil Substances 0.000 claims description 83
- 239000003814 drug Substances 0.000 claims description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 239000012071 phase Substances 0.000 claims description 30
- 235000014593 oils and fats Nutrition 0.000 claims description 29
- 230000036541 health Effects 0.000 claims description 28
- 239000008346 aqueous phase Substances 0.000 claims description 23
- 239000003995 emulsifying agent Substances 0.000 claims description 22
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 19
- 230000002402 anti-lipaemic effect Effects 0.000 claims description 19
- 230000003078 antioxidant effect Effects 0.000 claims description 19
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 claims description 18
- 239000003963 antioxidant agent Substances 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 16
- 240000008415 Lactuca sativa Species 0.000 claims description 15
- 235000012045 salad Nutrition 0.000 claims description 15
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 14
- 230000001804 emulsifying effect Effects 0.000 claims description 11
- 239000012567 medical material Substances 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 11
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 10
- 229940069338 potassium sorbate Drugs 0.000 claims description 10
- 235000010241 potassium sorbate Nutrition 0.000 claims description 10
- 239000004302 potassium sorbate Substances 0.000 claims description 10
- 244000068988 Glycine max Species 0.000 claims description 9
- 235000010469 Glycine max Nutrition 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000009413 insulation Methods 0.000 claims description 9
- 239000004250 tert-Butylhydroquinone Substances 0.000 claims description 9
- 235000019281 tert-butylhydroquinone Nutrition 0.000 claims description 9
- 235000011078 sorbitan tristearate Nutrition 0.000 claims description 8
- IJCWFDPJFXGQBN-BIFNRIDTSA-N sorbitan tristearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@@H](O)[C@@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-BIFNRIDTSA-N 0.000 claims description 8
- 238000012423 maintenance Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000013517 stratification Methods 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 claims description 6
- HVUMOYIDDBPOLL-XGKPLOKHSA-N [2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XGKPLOKHSA-N 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 239000006185 dispersion Substances 0.000 claims description 6
- 238000003801 milling Methods 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 239000004576 sand Substances 0.000 claims description 6
- 238000010025 steaming Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000007738 vacuum evaporation Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 1
- 241000628997 Flos Species 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 235000019198 oils Nutrition 0.000 description 64
- 238000000034 method Methods 0.000 description 18
- 239000000839 emulsion Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 235000008216 herbs Nutrition 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- 239000002199 base oil Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 235000013348 organic food Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 108700022737 rat Fat1 Proteins 0.000 description 1
- 239000010517 refined sesame oil Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000010729 system oil Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 239000002569 water oil cream Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to lipid-reducing healthcare oil.The lipid-reducing healthcare oil is prepared from traditional Chinese medicinal materials including, by weight, 2-5 parts of Fructus Lycii, 1-4 parts of Fructus Crataegi, 2-4 parts of Semen Ziziphi Spinosae, 2-5 parts of Radix Puerariae, 1.5-3 parts of Semen Cassiae, 1-3 parts of Semen Raphani, 0.5-2 parts of Flos Carthami, 1-3 parts of Folium Mori, 1.5-4 parts of Bulbus Allii Macrostemoni, 0.5-3 parts of Rhizoma Ligustici Wallichii and 1-3 parts of Rhizoma Alismatis.
Description
Technical field:
The present invention relates to a kind of edible health oil product, particularly to a kind of Antilipemic health oil product.
Background technology:
Oils and fats is one of requisite food of people's daily life. The local flavor that the requirement of oils and fats not only to have been had by people, but also the requirement of unsoundness and nutrition. Now, good health and a long life have become people's question of common concern, and research and development nourishing healthy oils and fats is also one of focus of oils and fats research in recent years. Traditional view is thought, the major function of oils and fats is to provide nutrition and good local flavor, and occurring of nourishing healthy oils and fats will undoubtedly to the content that oil prodution industry injection is new.
Health protection with Chinese medicine product are based on theory of Chinese medical science, for raw material or add health promoting product prepared by the mode of Chinese herbal medicine extract with Chinese herbal medicine, such as relevant functional health-care food, natural prodcuts, pollution-free food, Organic food, enhancing immunity product, anti-aging product, preventing and treating cardiovascular disease product, antineoplastic product, liver protecting and kidney invigorating product, marine organisms goods, subtract weight gaining health product, aminoacid, hematinic, fatty acid, edible fiber, new resource food, trace element product etc.; Food therapy product: food therapy raw material and relevant device, tonic medical material (ginseng/young pilose antler/Cordyceps etc.), the prepared slices of Chinese crude drugs, national characters medicine and Chinese traditional herbs, crude drug and extract etc.
Edible oil and fat being equipped with Chinese medicine as edible health oil product, current product is less, and the present invention passes through the research to Chinese medical theory and scientific experiments, has invented a kind of health-care oil product with lipid-reducing function.
Summary of the invention:
The present invention provides a kind of Antilipemic health oil, and it is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
Preferably, the Antilipemic health oil of the present invention, it is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
Most preferred, the Antilipemic health oil of the present invention, it is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
The present invention is on the Chinese medicine basis of above proportioning, carries out Chinese crude drug extracting processing, and by oil immersion, decocting in water, oil-water separation, the step such as oil-water emulsion prepares into a kind of edible oil emulsions, i.e. the Antilipemic health oil of the present invention.
Antilipemic health of the present invention oil, its preparation method is as follows:
Step 1,
Chinese crude drug is pulverized, and adds salad oil, and heat-insulation soaking 10-15 hour at 95 DEG C~105 DEG C, then add water fried 2-5h, and oil-water separation, oil phase is standby.
Step 2,
Aqueous phase, adds the activated carbon of 2%~5%, at 85 DEG C~95 DEG C insulated and stirred 1h~2h, concentrates after filtration, and concentrated solution is standby.
Step 3,
In oil phase add Fructus Maydis oil, Oleum Arachidis hypogaeae semen, Oleum sesami, add emulsifying agent, and aqueous phase carries out emulsifying, homogenizing obtain the present invention Antilipemic health oil.
Wherein, the part by weight of four kinds of oils and fatss is as follows
Preferably, the part by weight of four kinds of oils and fatss is as follows
Preferably, the preparation method of the present invention:
Wherein the Chinese crude drug in step 1 first through drying, chopping up, parch, then pulverize, 10~20 orders sieve, and the amount adding salad oil is medical material weight 1.5-2.5 times. Add 0.5-1.5 times that amount is medical material weight of water
The wherein concentration in step 2, selected from vacuum evaporation, steams the water of wherein 80%.
Wherein the emulsifying agent in step 3 is selected from: Span60 and Tween60, antioxidant or preservative can be added if desired, described antioxidant is selected from: the excellent precious TBHQ antioxidant in Guangzhou, make consumption 0.02% (percentage by weight), and add the citric acid of people's a small amount of (about 0.001%) (percentage by weight), preservative is selected from: potassium sorbate 0.1% (percentage by weight)
The formula of the present invention and preparation method obtain through screening, and screening process is as follows:
1 experimental section
Choosing and pharmacology of 1.1 integration of edible and medicinal herbs Chinese crude drugs
1.1.I formula and pharmacology Fructus Lycii, Fructus Crataegi, Semen Ziziphi Spinosae, Radix Puerariae, Semen Cassiae, Semen Raphani, Flos Carthami, Folium Mori, Bulbus Allii Macrostemonis, Rhizoma Chuanxiong, Rhizoma Alismatis.
1.1.2 active substance and recommendation health care consumption in selected Chinese crude drug, in Table 1.
The active substance of table 1 " Antilipemic health oil " Chinese herbal medicine and recommendation health care consumption
" Antilipemic health oil " is the physiological characteristics grown according to " Nian Sishi, half of YIN QI consumed " expectorant stasis of blood and the formula designed. In prescription, Fructus Lycii, Semen Ziziphi Spinosae, Radix Puerariae have yin nourishing benefit essence effect, the effect of invigorating blood circulation of Folium Mori, Bulbus Allii Macrostemonis, Rhizoma Chuanxiong, Rhizoma Alismatis diuresis, Bulbus Allii Macrostemonis, Rhizoma Chuanxiong circulation of qi promoting, Semen Cassiae intestine moistening. Having benefit to have to rush down, remove the rotten and let fresh grow, enhance metabolism, maintain organism balance, full presciption medicine thing all has the effect of blood fat reducing in various degree, blood pressure lowering, blood circulation promoting, therefore the cardiovascular and cerebrovascular disease that person in middle and old age are common is had functions of prevention and health care.
1.2 nourishing healthy oil making technology experiments
1.2.1 the formula of substrate oils and fats
The purpose of formula is to meet the requirement of basic fatty acid composition to improve local flavor and the mouthfeel of health-care oil.
The formula of table 2 substrate oils and fats
Note: salad oil is soybean salad oil or rape salad oil
1.2.2 the extraction process of active substance in selected integration of edible and medicinal herbs medical material
Traditional instructions of taking of Chinese medicine is that decocting in water makes soup, then takes. Making in the process of soup at decocting in water, major part water soluble ingredient enters people's soup, also has part oil-soluble part and aqueous solution to form heterogeneous emulsification system, wherein also has the minimum solid suspension of part, thus common Chinese medicinal decoction is dark muddy liquid. In order to extract effective oil soluble part in Chinese crude drug fully.
The following extraction process of special employing:
Chinese crude drug first through drying, chopping up, parch, then pulverize, 10~20 orders sieve, add the soybean salad oil of medical material weight 2 times, at 95 DEG C~105 DEG C, insulation leaching system is overnight. about 12h, and then add the medical material fried maintenance bottom water of 1 times of weight pure water and be in fluidized state, depress at 1 standard atmosphere, due to upper strata oils and fats, make water boiling point raise, therefore boiling temperature is about 100 DEG C~105 DEG C unlimited boiling 4h, then filters, oils and fats and aqueous solution are through stratification, then are separated. Oils and fats cooling after separately is standby, and the aqueous solution of layering adds the activated carbon of 2%~5%, at 85 DEG C~95 DEG C insulated and stirred 1h~2h, carry out decolouring, taking off taste, refilter, by filter vacuum evaporation and concentration, to remove the water of wherein 80%, the cooling of this concentrated solution is standby.
Main technologic parameters is as follows:
Pulverizing medicinal materials 10 mesh sieve. Oils and fats soaks system oil/medical material anharmonic ratio 2.5:1 ratio conveniently, temperature 95 DEG C~105 DEG C, about 12h. Adding water, water/medical material weight ratio 1.5:1,100 DEG C~105 DEG C decocting in water of temperature, water are for 4h, aqueous phase active carbon for decolorization amount 2%~5% (weight), insulated and stirred 1h~2h at 80 DEG C~95 DEG C. Vacuum concentrates, and under 20kPa vacuum, the moisture of wherein 80% is fallen in concentration.
1.2.3 the selection of emulsifying agent
HLB value needed for emulsifying multiple eating oil is 6~12, selects Span60 and Tween60 to prepare a series of emulsion as emulsifying agent. The HLB of Span60 is the HLB of 4.7, Tween60 is 14.9. Additivity principle according to emulsifier hlb value has prepared a series of emulsifying agent, and tests the required emulsifying agent minimum drawing stable emulsion, and variation tendency is table 3 such as.
Table 3 emulsifier situation of change
Span60 and Tween60 is best as the emulsifying effectiveness of blended emulsifier.
1.2.4 the preparation of emulsion
In the process for preparation of emulsion, be respectively adopted feed way three kinds different and tested, i.e. agent-in-water method, agent-in-oil method and in turn liquid feeding method.
Blended emulsifier, in this method, is directly dissolved in water by agent-in-water method, is added by oil under vigorous stirring and forms.
This method of agent-in-oil method is also known as phase conversion emulsifying or " civil law ". This method is to add in oil phase by blended emulsifier, at Jia Renshui. fierceness is stirred companion and is formed.
This method of liquid feeding method is also known as " admiralty method " in turn. This normal direction water and oil add blended emulsifier in turn, only adds a small amount of every time, after high degree of agitation.
Emulsion prepared by above-mentioned three kinds of modes is carried out stability test, and result is table 4 such as. As shown in Table 4, the most stable with the made emulsion joined of agent-in-oil method.
4 three kinds of distinct methods of table make the stability of emulsion
1.2.5 the screening of antioxidant
For ensureing nourishing healthy oil oxidation stability screening antioxidant, find that the excellent precious TBHQ antioxidant effect in Guangzhou is better, make consumption 0.02% (weight), and add the citric acid of people's a small amount of (about 0.001%), add potassium sorbate 0.1% as preservative, the change of peroxide value and acid number such as table 5 after measured.
The change of over hydrogenation value and acid number after table 5 health-care oil addition TBHQ antioxidant
Note: add the oil sample of people antioxidant TBHQ and potassium sorbate preservative and do not add the blank sample of the above-mentioned additive of people, depositing in the calorstat of 37 DEG C simultaneously, and monthly regular mensuration its cross softness value and acid number.
Can be seen that from upper table, add antioxidant TBHQ and there is obvious antioxidant effect.
2 conclusions
2.1 using the compound lard of 80% soybean salad oil, 2% refined sesame oil, 10% Fructus Maydis oil and the 8% heavy fragrant peanut oil carrier oils and fats as nutrition oil. The fatty acid of this carrier oils and fats forms such as table 6.
The fatty acid composition of table 6 nutrition oil
Choose above-mentioned carrier oils and fats and can also well shelter the bad smell brought into due to Chinese medicine ingredients, and make nutrition oil have good taste and local flavor.
The integration of edible and medicinal herbs medical material that 2.2 screen is as follows: Fructus Lycii, Fructus Crataegi, Semen Ziziphi Spinosae, Radix Puerariae, Semen Cassiae, Semen Raphani, Flos Carthami, Folium Mori, Bulbus Allii Macrostemonis, Rhizoma Chuanxiong, Rhizoma Alismatis.
Chinese crude drug is through cleaning, dry, shred, pulverize, steaming stir-fry, pulverize then through pulverizer, sieve through 10~20 mesh sieve, add the soybean salad oil of 2 times of weight, at 95 DEG C~105 DEG C, 12h processed is soaked in insulation, be subsequently adding 1~1.5 times of deionized water, maintenance water is in slight boiling condition, uncovered fried 4h in bottom, filters through filter plant, by oil phase and aqueous phase stratification, making biphase separating in phase separator, oil phase cools down, and aqueous phase adds 2%~5% activated carbon, 2h is stirred at 80 DEG C~85 DEG C, refilter, filter vacuum is concentrated, remove the water of wherein 80%.
2.3 add other oils and fats by above-mentioned requirements in oil phase, it is subsequently adding the blended emulsifier (wherein be 34%Tween60 and 66%Span65 containing weight ratio) of 0.1% (weight), aqueous phase emulsifying after concentrating with vacuum again, homogenizing 0.5h (rotating speed 14000r/min), it is 0.02% (weight), potassium sorbate 0.1% (weight) by antioxidant TBHQ, sand milling is sheared dispersion 6h~8h add, continue homogenizing 1.5~2h.
2.4 modes pressing carrier oils and fats agent-in-oil method, add nutrition oil prepared by the blended emulsifier (wherein containing 34%Tween60 and 66%Span65) of 0.1, steady quality, have health function.
3 functional experiments
3.1 functional check conclusions: inspection experiments show that, sample can suppress the rising of feed height fat nutrient fodder rat blood serum TG and cholesterol, increases high density lipoprotein, has obvious regulating blood lipid action.
Lipid-lowering test
Lipid determination: the rat blood serum T-CHOL (TC) of rating model group and inventive samples group, triglyceride (TG), LDL-C (LDL-C), highdensity lipoprotein-cholesterol (HDL-C),
Rat fat changes
The each blood lipids index of rat giving medicine of the present invention while feeding high lipid food is clearly better. Wherein, TG, TC and the LDL-C level of heavy dose of experimental group rat is compared model group and is decreased obviously. The HDL-C level of of the present invention group of rat compares model group HDL-C level tool significant difference.
Experimental result is shown in following table:
3.2 toxicological experiments: the Kunming mouse Oral toxicity to two kinds of sexes, gavage concentration reaches 20ml/kg.bw successively, observes one week, does not find poisoning symptom, also without dead, specifies by acute toxicity grading criteria, and this experiment thing belongs to nontoxic level class material. Three mutagenic test results are feminine gender. The composition described above of the present invention is by weight as proportioning, can increase according to corresponding proportion when producing or reduce, as large-scale production can by kilogram in units of, or in units of ton, small-scale production can also in units of milligram, weight can increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.
The ratio of above weight proportion obtains through science screening, for special circumstances, such as serious symptom or mild, fat or modest, it is possible to the proportioning of the corresponding amount adjusting composition, increases or reduces less than 100%, and drug effect is constant.
The health-care oil of the present invention, can be prepared as pharmaceutical dosage forms as required, as added pharmaceutically acceptable carrier, prepares according to the routine techniques of galenic pharmacy. The pharmaceutical dosage forms of the present invention, it is possible to selected from dosage forms such as capsule, soft gelatin capsules, it is also possible to prepare into oral liquid.
The present invention is found surprisingly that, and the collocation of each component of the present invention has synergistic function, has the health-care effect of blood fat reducing, blood pressure lowering, blood circulation promoting.
Detailed description of the invention:
Further illustrate the present invention by the following examples, but not as limitation of the present invention.
Embodiment 1
The present invention provides a kind of Antilipemic health oil, and it is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
The part by weight of four kinds of oils and fatss is as follows
Preparation method is as follows:
Chinese crude drug is through cleaning, dry, shred, pulverize, steaming stir-fry, pulverize then through pulverizer, sieve through 10~20 mesh sieve, add the soybean salad oil of 2 times of weight, at 95 DEG C~105 DEG C, 12h processed is soaked in insulation, be subsequently adding 1~1.5 times of deionized water, maintenance water is in slight boiling condition, uncovered fried 4h in bottom, filters through filter plant, by oil phase and aqueous phase stratification, making biphase separating in phase separator, oil phase cools down, and aqueous phase adds 2%~5% activated carbon, 2h is stirred at 80 DEG C~85 DEG C, refilter, filter vacuum is concentrated, remove the water of wherein 80%.
Oil phase adds other oils and fats, it is subsequently adding the blended emulsifier (wherein containing 34%Tween60 and 66%Span65) of 0.1% (weight), aqueous phase emulsifying after concentrating with vacuum again, addition antioxidant TBHQ0.02% (weight), potassium sorbate 0.1% (weight) homogenizing 2h (rotating speed 14000r/min), sand milling is sheared dispersion 6h~8h add, continue homogenizing 1.5~2h.
Embodiment 2
The present invention provides a kind of Antilipemic health oil, and it is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
The part by weight of four kinds of oils and fatss is as follows
Preparation method is as follows:
Chinese crude drug is through cleaning, dry, shred, pulverize, steaming stir-fry, pulverize then through pulverizer, sieve through 10~20 mesh sieve, add the soybean salad oil of 2 times of weight, at 95 DEG C~105 DEG C, 12h processed is soaked in insulation, be subsequently adding 1~1.5 times of deionized water, maintenance water is in slight boiling condition, uncovered fried 4h in bottom, filters through filter plant, by oil phase and aqueous phase stratification, making biphase separating in phase separator, oil phase cools down, and aqueous phase adds 2%~5% activated carbon, 2h is stirred at 80 DEG C~85 DEG C, refilter, filter vacuum is concentrated, remove the water of wherein 80%.
Oil phase adds other oils and fats, it is subsequently adding the blended emulsifier (wherein containing 34%Tween60 and 66%Span65) of 0.1% (weight), aqueous phase emulsifying after concentrating with vacuum again, addition antioxidant TBHQ0.02% (weight), potassium sorbate 0.1% (weight) homogenizing 2h (rotating speed 14000r/min), sand milling is sheared dispersion 6h~8h add, continue homogenizing 1.5~2h.
Embodiment 3
The present invention provides a kind of Antilipemic health oil, and it is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
The part by weight of four kinds of oils and fatss is as follows
Preparation method is as follows:
Chinese crude drug is through cleaning, dry, shred, pulverize, steaming stir-fry, pulverize then through pulverizer, sieve through 10~20 mesh sieve, add the soybean salad oil of 2 times of weight, at 95 DEG C~105 DEG C, 12h processed is soaked in insulation, be subsequently adding 1~1.5 times of deionized water, maintenance water is in slight boiling condition, uncovered fried 4h in bottom, filters through filter plant, by oil phase and aqueous phase stratification, making biphase separating in phase separator, oil phase cools down, and aqueous phase adds 2%~5% activated carbon, 2h is stirred at 80 DEG C~85 DEG C, refilter, filter vacuum is concentrated, remove the water of wherein 80%.
Oil phase adds other oils and fats, it is subsequently adding the blended emulsifier (wherein containing 34%Tween60 and 66%Span65) of 0.1% (weight), aqueous phase emulsifying after concentrating with vacuum again, addition antioxidant TBHQ0.02% (weight), potassium sorbate 0.1% (weight) homogenizing 2h (rotating speed 14000r/min), sand milling is sheared dispersion 6h~8h add, continue homogenizing 1.5~2h.
Embodiment 4
Preparation method:
Chinese crude drug is through cleaning, dry, shred, pulverize, steaming stir-fry, pulverize then through pulverizer, sieve through 10~20 mesh sieve, add the soybean salad oil of 2 times of weight, at 95 DEG C~105 DEG C, 12h processed is soaked in insulation, be subsequently adding 1~1.5 times of deionized water, maintenance water is in slight boiling condition, uncovered fried 4h in bottom, filters through filter plant, by oil phase and aqueous phase stratification, making biphase separating in phase separator, oil phase cools down, and aqueous phase adds 2%~5% activated carbon, 2h is stirred at 80 DEG C~85 DEG C, refilter, filter vacuum is concentrated, remove the water of wherein 80%.
In oil phase, other oils and fats is added by above-mentioned requirements, it is subsequently adding the blended emulsifier (wherein containing 34%Tween60 and 66%Span65) of 0.1% (weight), aqueous phase emulsifying after concentrating with vacuum again, homogenizing 0.5h (rotating speed 14000r/min), it is 0.02% (weight), potassium sorbate 0.1% (weight) by antioxidant TBHQ, sand milling is sheared dispersion 6h~8h add, continue homogenizing 1.5~2h.
Claims (10)
1. an Antilipemic health oil, it is characterised in that it is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
2. Antilipemic health according to claim 1 oil, it is characterised in that it is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
3. Antilipemic health according to claim 1 oil, it is characterised in that it is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
4. the preparation method of the Antilipemic health oil described in claim 1, it is characterised in that step is as follows:
Step 1,
Chinese crude drug is pulverized, and adds salad oil, heat-insulation soaking 10-15 hour at 95 DEG C~105 DEG C, and then add water fried 2-5h, oil-water separation, and oil phase is standby,
Step 2,
Aqueous phase, adds the activated carbon of 2%~5%, at 85 DEG C~95 DEG C insulated and stirred 1h~2h, concentrates after filtration, and concentrated solution is standby,
Step 3,
In oil phase add Fructus Maydis oil, Oleum Arachidis hypogaeae semen, Oleum sesami, add emulsifying agent, and aqueous phase carries out emulsifying, homogenizing obtain the present invention Antilipemic health oil,
Wherein, the part by weight of four kinds of oils and fatss is as follows
5. preparation method according to claim 4, it is characterised in that
Wherein the Chinese crude drug in step 1 first through drying, chopping up, parch, then pulverize, 10~20 orders sieve, and the amount adding salad oil is medical material weight 1.5-2.5 times. Add 0.5-1.5 times that amount is medical material weight of water.
6. preparation method according to claim 4, it is characterised in that
The wherein concentration in step 2, selected from vacuum evaporation, steams the water of wherein 80%.
7. the preparation method of the Antilipemic health oil described in claim 1, it is characterised in that
Wherein the emulsifying agent in step 3 is selected from: the mixture of Span60 and Tween60, it may be necessary to add antioxidant or preservative.
8. preparation method according to claim 7, it is characterised in that
Wherein said antioxidant is selected from: the excellent precious TBHQ antioxidant in Guangzhou, makes consumption 0.02%, and adds the citric acid of 0.001%, and preservative is selected from: potassium sorbate 0.1%,
Wherein, the part by weight of four kinds of oils and fatss is as follows
9. preparation method according to claim 7, it is characterised in that the mixture of emulsifying agent Span60 and Tween60, wherein containing 34%Tween60 and 66%Span65.
10. preparation method according to claim 7, it is characterised in that step is as follows:
Chinese crude drug is through cleaning, dry, shred, pulverize, steaming stir-fry, pulverize then through pulverizer, sieve through 10~20 mesh sieve, add the soybean salad oil of 2 times of weight, at 95 DEG C~105 DEG C, 12h processed is soaked in insulation, be subsequently adding 1~1.5 times of deionized water, maintenance water is in slight boiling condition, uncovered fried 4h in bottom, filters through filter plant, by oil phase and aqueous phase stratification, making biphase separating in phase separator, oil phase cools down, and aqueous phase adds 2%~5% activated carbon, 2h is stirred at 80 DEG C~85 DEG C, refilter, filter vacuum is concentrated, remove the water of wherein 80%;
Oil phase adds other oils and fats, it is subsequently adding the blended emulsifier of 0.1%, it is wherein 34%Tween60 and 66%Span65 containing weight ratio, then aqueous phase emulsifying after concentrating with vacuum, homogenizing 0.5h, rotating speed 14000r/min,, by 0.02% antioxidant TBHQ, 0.1% potassium sorbate, sand milling is sheared dispersion 6h~8h and adds, continue homogenizing 1.5~2h, to obtain final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610032010.2A CN105661542A (en) | 2016-01-19 | 2016-01-19 | Lipid-reducing healthcare oil |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610032010.2A CN105661542A (en) | 2016-01-19 | 2016-01-19 | Lipid-reducing healthcare oil |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105661542A true CN105661542A (en) | 2016-06-15 |
Family
ID=56301454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610032010.2A Pending CN105661542A (en) | 2016-01-19 | 2016-01-19 | Lipid-reducing healthcare oil |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105661542A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106753752A (en) * | 2016-12-13 | 2017-05-31 | 青岛嘉瑞生物技术有限公司 | A kind of health-care salicorne oil beneficial to hypotensive |
CN108157530A (en) * | 2018-01-19 | 2018-06-15 | 柳州市鱼峰区倪氏味之坊屏山店螺蛳粉休闲餐吧 | A kind of nutrient and flavour salad oil |
CN108175063A (en) * | 2018-01-19 | 2018-06-19 | 柳州市鱼峰区倪氏味之坊屏山店螺蛳粉休闲餐吧 | A kind of production method of instant banana flowers |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1298698A (en) * | 2000-05-26 | 2001-06-13 | 湖南金键米业股份有限公司 | Health-care oil for regulating blood fat |
CN1416879A (en) * | 2002-11-27 | 2003-05-14 | 天大药业(深圳)有限公司 | Antilipemic Chinese medicine |
CN1440804A (en) * | 2003-03-31 | 2003-09-10 | 江西汇仁药业有限公司 | Antilipemic Chinese medicine |
CN101219175A (en) * | 2007-01-09 | 2008-07-16 | 李青 | Weight reducing essential oil |
CN101292685A (en) * | 2007-04-26 | 2008-10-29 | 赵凯 | Health care edible oil |
KR20090085876A (en) * | 2008-02-05 | 2009-08-10 | 한상노 | Vitamin Tree Extracts and Fractions thereof |
CN104257839A (en) * | 2014-10-17 | 2015-01-07 | 山东省中医药研究院 | Traditional Chinese medicine composition with effects of reducing blood glucose and blood fat and protecting vascular endothelium and preparation method thereof |
CN104256008A (en) * | 2014-09-27 | 2015-01-07 | 山东吴氏恒康健康科技有限公司 | Crataegus pinnatifida bunge and semen cassiae tea and preparation method thereof |
-
2016
- 2016-01-19 CN CN201610032010.2A patent/CN105661542A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1298698A (en) * | 2000-05-26 | 2001-06-13 | 湖南金键米业股份有限公司 | Health-care oil for regulating blood fat |
CN1416879A (en) * | 2002-11-27 | 2003-05-14 | 天大药业(深圳)有限公司 | Antilipemic Chinese medicine |
CN1440804A (en) * | 2003-03-31 | 2003-09-10 | 江西汇仁药业有限公司 | Antilipemic Chinese medicine |
CN101219175A (en) * | 2007-01-09 | 2008-07-16 | 李青 | Weight reducing essential oil |
CN101292685A (en) * | 2007-04-26 | 2008-10-29 | 赵凯 | Health care edible oil |
KR20090085876A (en) * | 2008-02-05 | 2009-08-10 | 한상노 | Vitamin Tree Extracts and Fractions thereof |
CN104256008A (en) * | 2014-09-27 | 2015-01-07 | 山东吴氏恒康健康科技有限公司 | Crataegus pinnatifida bunge and semen cassiae tea and preparation method thereof |
CN104257839A (en) * | 2014-10-17 | 2015-01-07 | 山东省中医药研究院 | Traditional Chinese medicine composition with effects of reducing blood glucose and blood fat and protecting vascular endothelium and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
宋光森等: "降脂营养保健油的研制", 《中国油脂》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106753752A (en) * | 2016-12-13 | 2017-05-31 | 青岛嘉瑞生物技术有限公司 | A kind of health-care salicorne oil beneficial to hypotensive |
CN108157530A (en) * | 2018-01-19 | 2018-06-15 | 柳州市鱼峰区倪氏味之坊屏山店螺蛳粉休闲餐吧 | A kind of nutrient and flavour salad oil |
CN108175063A (en) * | 2018-01-19 | 2018-06-19 | 柳州市鱼峰区倪氏味之坊屏山店螺蛳粉休闲餐吧 | A kind of production method of instant banana flowers |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106962506A (en) | A kind of ready-mixed oil and preparation method thereof | |
CN102907677A (en) | Sea-buckthorn perilla seed oil soft capsule having function of assisting blood-fat reduction and preparation method thereof | |
CN101658210A (en) | Perilla sesame oil and preparation method as well as application thereof | |
CN105996028B (en) | Ginger extract, ginger fiber and preparation method of ginger extract and ginger fiber | |
CN105661542A (en) | Lipid-reducing healthcare oil | |
CN103348812A (en) | Tea polyphenol healthy tea oil and preparation method thereof | |
US10227547B2 (en) | Astragalus membranaceus seed raw oil, refined oil, preparation method therefor and use thereof | |
CN106942397A (en) | A kind of edible blend oil with reducing blood lipid and blood pressure reduction effect | |
CN107509820A (en) | A kind of nutrition and health care chilli oil and preparation method thereof | |
CN103960377B (en) | Woody cereal oil and preparation method thereof | |
CN108244270A (en) | A kind of lipid-loweringing edible oil and preparation method thereof | |
CN106418542A (en) | Health-care product having function of regulating blood lipids and preparation method thereof | |
CN107156347A (en) | It is a kind of to be used for reducing blood lipid, health protection tea of blood pressure and preparation method thereof | |
CN102805160B (en) | Special camellia oleifera abel for aged people and preparation method of same | |
CN106107978A (en) | A kind of unknown mallow health care oral liquid of blood pressure lowering | |
CN102599265B (en) | Vitex flower seed oil and production method thereof | |
CN105802726A (en) | Health-care peony seed oil and preparation method thereof | |
CN106433949A (en) | Low-acid-value Yunnan pine seed oil, preparation method and application thereof | |
CN105076492A (en) | Peanut oil capable of improving immunologic function and preparing method thereof | |
CN102580108A (en) | Novel oily liquid auxiliary material for soft capsules for reducing blood fat | |
CN1284351A (en) | Red sage containing medicine composition and its preparation and use | |
CN112970860B (en) | Selenium-rich lipid-lowering edible oil and preparation method thereof | |
CN109316565A (en) | A kind of blood-fat reducing composition and its preparation method and application | |
CN108850827A (en) | A kind of alimentary paste of conditioning subhealthy state and preparation method thereof | |
CN103734593B (en) | Production process of healthy food compound American ginseng rice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160615 |